Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables

Gynecologic Oncology

Volumn 133, Issue 1, 2014, Pages 43-47

  Joehlin Price, Amy S ^a   Perrino, Carmen M ^b   Stephens, Julie ^c   Backes, Floor J ^c   Goodfellow, Paul J ^c   Cohn, David E ^c   Suarez, Adrian A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

BMI; Body mass index; DNA mismatch repair protein; Endometrial cancer; MMR

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER STAGING; CLEAR CELL CARCINOMA; COHORT ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM ABLATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UNDIFFERENTIATED CARCINOMA; VERY ELDERLY;

BMI; BODY MASS INDEX; DNA MISMATCH REPAIR PROTEIN; ENDOMETRIAL CANCER; MMR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA, CLEAR CELL; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA; CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84897434785     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.017     Document Type: Article

References (44)

1. N.E. Allen, T.J. Key, L. Dossus, S. Rinaldi, A. Cust, and A. Lukanova et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 15 2 2008 485 497
2. T. Bjorge, T. Stocks, A. Lukanova, S. Tretli, R. Selmer, and J. Manjer et al. Metabolic syndrome and endometrial carcinoma Am J Epidemiol 171 8 2010 892 902
3. K.W. Reeves, G.C. Carter, R.J. Rodabough, D. Lane, S.G. McNeeley, and M.L. Stefanick et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative Gynecol Oncol 121 2011 376 382
4. A.P. Polednak Estimating the number of US incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers Cancer Detect Prev 32 3 2008 190 199
5. L. Dossus, H. Rinaldi, S. Becker, A. Lukanova, A. Tjonneland, and A. Olsen Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study Endocr Relat Cancer 17 4 2010 1007 1019
6. C.K. McCourt, D.G. Mutch, R.K. Gibb, J.S. Rader, P.J. Goodfellow, and K. Trinkaus et al. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer Gynecol Oncol 104 2007 535 539
7. T. Miyamoto, T. Shiozawa, H. Kashima, Y.Z. Feng, A. Suzuki, and M. Kurai et al. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells Endocrinology 147 2006 4863 4870
8. G.M. Li Mechanisms and functions of DNA mismatch repair Cell Res 18 2008 85 98
9. J.I. Risinger, A. Berchuck, M.F. Kohler, P. Watson, H.T. Lynch, and J. Boyd Genetic instability of microsatellites in endometrial carcinoma Cancer Res 53 21 1993 5100 5103
10. L.M. Peterson, B.R. Kipp, K.C. Halling, S.E. Kerr, D.I. Smith, and T.J. Distad et al. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis Int J Gynecol Pathol 31 3 2012 195 205
11. T.A. Kunkel, and D.A. Erie DNA mismatch repair Annu Rev Biochem 74 2005 681 710
12. J. Shia Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome J Mol Diagn 10 4 2008 293 300
13. M. Esteller, R. Levine, S.B. Baylin, L.H. Ellenson, and J.G. Herman MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas Oncogene 17 18 1998 2413 2417
14. S.B. Simpkins, T. Bocker, E.M. Swisher, D.G. Mutch, D.J. Gersell, and A.J. Kovatich et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers Hum Mol Genet 8 4 1999 661 666
15. H. Katabuchi, B. van Rees, A.R. Lambers, B.M. Ronnet, M.S. Blazes, and F.S. Leach et al. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas Cancer Res 55 23 1995 5556 5560
16. H. Hampel, W. Frankel, J. Panescu, J. Lockman, K. Sotamaa, and D. Fix et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients Cancer Res 66 2006 7810 7817
17. V. Bonadona, B. Bonaiti, S. Olschwang, S. Grandjouan, L. Huiart, and M. Longy et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 305 22 2011 2304 2310
18. K. Munstedt, M. Wagner, U. Kullmer, A. Hackethal, and F.E. Franke Influence of body mass index on prognosis in gynecological malignancies Cancer Causes Control 19 9 2008 909 916
19. A.S. Felix, J.L. Weissfeld, R.A. Stone, R. Bowser, M. Chivukula, and R.P. Edwards et al. Factors associated with Type I and Type II endometrial cancer Cancer Causes Control 21 2010 1851 1856
20. K.K. Mauland, J. Trovik, E. Wik, M.B. Raeder, T.S. Njolstad, and I.M. Stefansson et al. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer Br J Cancer 104 2011 921 926
21. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
22. E. Everett, H. Tamimi, B. Greer, E. Swisher, P. Paley, and L. Mandel et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer Gynecol Oncol 90 1 2003 150 157
23. J.C. Pavelka, I. Ben-Shachar, J.M. Fowler, N.C. Ramirez, and L.J. Copeland et al. Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients Gynecol Oncol 95 3 2004 588 592
24. B. Anderson, J.P. Connor, J.I. Andrews, C.S. Davis, R.E. Buller, and J.I. Sorosky et al. Obesity and prognosis in endometrial cancer Am J Obstet Gynecol 174 1996 1171 1179
25. I. Modica, R.A. Soslow, D. Black, C. Tornos, N. Kauff, and J. Shia Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma Am J Surg Pathol 31 2007 744 751
26. M.S. Pino, and D.C. Chung Application of molecular diagnostics for the detection of Lynch syndrome Expert Rev Mol Diagn 10 2010 651 665
27. C.S. Walsh, A. Blum, A. Walts, R. Alsabeh, H. Tran, and H.P. Koeffler et al. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening Gynecol Oncol 116 2010 516 521
28. K. Garg, M.M. Leitao Jr., N.D. Kauff, J. Hansen, K. Kosarin, and J. Shia et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities Am J Surg Pathol 33 2009 925 933
29. D.E. Cohn, J.C. Pavelka, W.L. Frankel, C.D. Morrison, H. Hampel, and L.J. Copeland et al. Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer? Int J Gynecol Cancer 18 2008 136 140
30. F.J. Backes, M.E. Leon, I. Ivanov, A. Suarez, W.L. Frankel, and H. Hampel et al. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer Gynecol Oncol 114 2009 486 490
31. K.S. Matthews, J.M. Estes, M.G. Conner, U. Manne, J.M. Whitworth, and W.K. Huh et al. Lynch syndrome in women less than 50 years of age with endometrial cancer Obstet Gynecol 111 2008 1161 1166
32. K.S. Grzankowski, D.M. Shimizu, C. Kimata, M. Black, and K.Y. Terada Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression Gynecol Oncol 126 3 2012 408 412
33. R. Yiu, H. Qui, S.H. Lee, and J. Garcia-Aguilar Mechanisms of microsatellite instability in colorectal cancer patients in different age groups Dis Colon Rectum 48 2005 2061 2069
34. H. Nakagawa, G.J. Nuovo, E.E. Zervos, E.W. Martin Jr., R. Salovaara, and L.A. Aaltonen et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer Cancer Res 61 2001 6991 6995
35. L.A. Meyer, R.R. Broaddus, and K.H. Lu Endometrial cancer and Lynch syndrome: clinical and pathologic considerations Cancer Control 16 1 2009 14 22
36. F.J. Backes, and D.E. Cohn Lynch syndrome Clin Obstet Gynaecol 54 2 2011 199 214
37. R.R. Broaddus, H.T. Lynch, L.M. Chen, M.S. Daniels, P. Conrad, and M.F. Munsell et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma Cancer 106 2006 87 94
38. M.S. Daniels Genetic testing by cancer site, uterus Cancer J 18 4 2012 338 342
39. K.H. Lu, J.O. Schorge, K.J. Rodabaugh, M.S. Daniels, C.C. Sun, and P.T. Soliman et al. Prospective determination of prevalence of Lynch Syndrome in young women with endometrial cancer J Clin Oncol 25 33 2007 5158 5164
40. F.J. Backes, E. Mitchell, H. Hampel, and D.E. Cohn Endometrial cancer patients and compliance with genetic counseling: room for improvement Gynecol Oncol 123 2011 532 536
41. M. Pollak Insulin and insulin-like growth factor signaling in neoplasia Nat Rev Cancer 8 12 2011 915 928
42. A.A. Hamid, M. Mandai, I. Konishi, K. Nabu, Y. Tsuruta, and T. Kusakari et al. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma Cancer 94 4 2002 997 1005
43. J.A. Irving, B. Dupuis, L. Wang, and C.B. Gilks Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometrium Fertil Steril 78 1 2002 195 196
44. M.L. Carcangiu, P. Radice, P. Casalini, L. Bertario, M. Merola, and P. Sala Lynch syndrome-related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types Int J Surg Pathol 18 2010 21 26